Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2

Journal of Clinical Investigation

Volumn 100, Issue 11, 1997, Pages 2824-2832

  Nakaoka, Takashi ^a   Gonda, Koichi ^b   Ogita, Teruhiko ^a   Otawara Hamamoto, Yoko ^b   Okabe, Fujiko ^a   Kira, Yuji ^c   Harii, Kiyonori ^b   Miyazono, Kohei ^d   Takuwa, Yoh ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Showa General Hospital   (Japan)

^d CANCER INSTITUTE   (Japan)

Author keywords

Adenovirus; Atherosclerosis; Balloon injury; Smooth muscle cell; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PROLINE; THYMIDINE; TRANSFORMING GROWTH FACTOR;

ADENOVIRUS; ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BALLOON CATHETER; CELL PROLIFERATION; COLLAGEN SYNTHESIS; DNA SYNTHESIS INHIBITION; EXTRACELLULAR MATRIX; GROWTH INHIBITION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031470417     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119830     Document Type: Article

References (43)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801-809.
2. Brown, G., J.J. Albers, L.D. Fisher, S.M. Schaefer, J.T. Lin, C. Kaplan, X.Q. Zhao, B.D. Bisson, V.F. Fitzpatrick, and H.T. Dodge. 1990. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med. 323:1289-1298.
3. Hansson, G.K., M. Hellstrand, L. Rymo, L. Rubbia, and G. Gabbiani. 1989. Interferon γ inhibits both proliferation and expression of differentiation-specific α-smooth muscle actin in arterial smooth muscle cells. J. Exp. Med. 170: 1595-1608.
4. Garg, U.C., and A. Hassid. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-1777.
5. Majack, R.A. 1987. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J. Cell Biol. 105: 465-471.
6. Battegay, E.J., E.W. Raines, R.A. Seifert, D.F. Bowen-Pope, and R. Ross. 1990. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 63:515-524.
7. Wozney, J.M., V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, R.W. Kriz, R.M. Hewick, and E.A. Wang. 1988. Novel regulators of bone formation: molecular clones and activities. Science. 242:1528-1534.
8. Hogan, B.L.M. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1580-1594.
9. Andrews, P.W., I. Damjanov, J. Berends, S. Kumpf, V. Zappavigna, F. Mavilio, and T.K. Sampath. 1994. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab. Invest. 71:243-251.
10. Yamashita, H., P. ten Dijke, D. Huylebroeck, T.K. Sampath, M. Andries, J.C. Smith, C.-H. Heldin, and K. Miyazono. 1995. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130:217-226.
11. Boström, K., K.E. Watson, S. Horn, C. Wortham, I.M. Herman, and L.L. Demer. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91:1800-1809.
12. Schluesener, H.J., and R. Meyermann. 1995. Immunolocalization of BMP-6, a novel TGF-β-related cytokine, in normal and atherosclerotic smooth muscle cells. Atherosclerosis. 113:153-156.
13. Kanegae, Y., G. Lee, Y. Sato, M. Tanaka, M. Nakai, T. Sakaki, S. Sugano, and I. Saito. 1995. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucl. Acids Res. 23:3816-3821.
14. Niwa, H., K. Yamamura, and J.-i. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:193-200.
15. Saito, I., Y. Oya, K. Yamamoto, T. Yuasa, and H. Shimojo. 1985. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 54:711-719.
16. Miyake, S., M. Makimura, Y. Kanegae, S. Harada, Y. Sato, K. Takamori, C. Tokuda, and I. Saito. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA. 93:1320-1324.
17. Kanegae, Y., M. Makimura, and I. Saito. 1994. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47:157-166.
18. Chamley-Campbell, J., G.R. Campbell, and R. Ross. 1979. The smooth muscle cell in culture. Physiol. Rev. 59:1-61.
19. Takuwa, Y., C. Ohse, E.A. Wang, J.M. Wozney, and K. Yamashita. 1991. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem. Biophys. Res. Commun. 174:96-101.
20. Guzman, R.J., P. Lemarchand, R.G. Crystal, S.E. Epstein, and T. Finkel. 1993. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation. 88:2838-2848.
21. Owens, G.K., A.A. Geisterfer, Y.W. Yang, and A. Komoriya. 1988. Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J. Cell Biol. 107:771-780.
22. 2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase. Biochem. J. 299:227-235.
23. Morisaki, N., M. Kawano, N. Koyama, T. Koshikawa, K. Umemiya, Y. Saito, and S. Yoshida. 1991. Effects of transforming growth factor-β1 on growth of aortic smooth muscle cells. Atherosclerosis. 88:227-234.
24. Chen, J.-K., H. Hoshi, and W.L. McKeehan. 1987. Transforming growth factor type β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA. 84:5287-5291.
25. Lawrence, R., D.J. Hartmann, and G.E. Sonenshein. 1994. Transforming growth factor β1 stimulates type V collagen expression in bovine vascular smooth muscle cells. J. Biol. Chem. 269:9603-9609.
26. Yamaguchi, A., T. Katagiri, T. Ikeda, J.M. Wozney, V. Rosen, E.A. Wang, A.J. Kahn, T. Suda, and S. Yoshiki. 1991. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113:681-687.
27. Cunningham, N.S., V. Paralkar, and A.H. Reddi. 1992. Osteogenin and recombinant hone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor β1 mRNA expression. Proc. Natl. Acad. Sci. USA. 89:11740-11744.
28. ten Dijke, P., H. Yamashita, T.K. Sampath, A.H. Reddi, M. Estevez, D.L. Riddle, H. Ichijo, C.-H. Heldin, and K. Miyazono. 1994. Identification of type I receptors for osteogenic protein-1 and bone morphogenic protein-4. J. Biol. Chem. 269:16985-16988.
29. Nakamura, T., K. Takio, Y. Eto, H. Shibai, K. Titani, and H. Sugino. 1990. Activin-binding protein from rat ovary is follistatin. Science. 247:836-838.
30. Saltis, J. 1996. TGF-β: receptors and cell cycle arrest. Mol. Cell. Endocrinol. 116:227-232.
31. Kojima, I., H. Mogami, N. Kawamura, H. Yasuda, and H. Shibata. 1993. Modulation of growth of vascular smooth muscle cells by activin A. Exp. Cell Res. 206:152-156.
32. Liu, F., A. Hata, J.C. Baker, J. Doody, J. Carcamo, R.M. Harland, and J. Massague. 1996. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature. 381:620-623.
33. Nikol, S., J.M. Isner, J.G. Pickering, M. Kearney, G. Leclerc, and L. Weir. 1992. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90:1582-1592.
34. Majesky, M.W., V. Lindner, D.R. Twardzik, S.M. Schwartz, and M.A. Reidy. 1991. Production of transforming growth factor β1 during repair of arterial injury. J. Clin. Invest. 88:904-910.
35. Israel, D.I., J. Nove, K.M. Kerns, I.K. Moutsatsos, and R.J. Kaufman. 1992. Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. Growth Factors. 7:139-150.
36. Ferns, G.A., E.W. Raines, K.H. Sprugel, A.S. Motani, M.A. Reidy, and R. Ross. 1991. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1129-1132.
37. Simons, M., E.R. Edelman, J.-L. DeKeyser, R. Lange, and R.D. Rosenberg. 1992. Antisense C-myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo. Nature. 359:67-70.
38. Indolfi, C., E.V. Avvedimento, A. Rapacciuolo, E. Di Lorenzo, G. Esposito E. Stabile, A. Feliciello, E. Mele, P. Giuliano, G. Condorelli, and M. Chiariello. 1995. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat. Med. 1:541-545.
39. Ohno, T., D. Gordon, H. San, V.J. Pompili, M.J. Imperiale, G.J. Nabel, and E.G. Nabel. 1994. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 265:781-784.
40. Guzman, R.J., E.A. Hirschowitz, S.L. Brody, R.G. Crystal, S.E. Epstein, and T. Finkel. 1994. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thvmidine kinase gene. Proc. Natl. Acad. Sci. USA. 91:10732-10736.
41. Chang, M.W., T. Ohno, D. Gordon, M.M. Lu, G.J. Nabel, E.G. Nabel, and J.M. Leiden. 1995. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol. Med. 1:172-181.
42. Rade, J.J., A.H. Schulick, R. Virmani, and D.A. Dichek. 1996. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat. Med. 2:293-298.
43. Chang, M.W., E. Barr, J. Seltzer, Y.-Q. Jiang, G.J. Nabel, E.G. Nabel, M.S. Parmacek, and J.M. Leiden. 1995. Cytostatic gene therapy for vascular proliferative disorders with constitutively active form of the retinoblastoma gene product. Science. 267:518-522.